GET DAILY SIGNALSWhy Is Mirion Technologies (MIR) Stock Down -8.15% Today?
Key Takeaways
- MIR shares fell 8.15% in trading on November 11, 2026, retreating from a prior close of $19.26 to about $17.69.
- The decline reflects profit-taking after a sharp multi-week rally, with the stock recently pushing toward its highest levels in months.
- Lingering margin concerns weigh on sentiment after the company's Q3 report lowered the top end of its adjusted EBITDA guidance and withdrew its prior 2028 margin target.
- Elevated front-loaded spending on AI and cybersecurity initiatives, alongside slower Medical-segment growth, remain key investor concerns.
- Recent analyst price-target reductions and a cautious ratings stance added pressure to the shares.
- Traders are watching upcoming Q4 execution, order-to-revenue conversion, and updated long-range guidance expected in early 2027.
- For more detail on the stock's Price Targets, Earnings, and Forecast, explore these dedicated pages.
- Discover AI-driven trading ideas for this and other tickers by exploring Trending AI Robots.
Opening Summary
Mirion Technologies, Inc. (MIR), an Atlanta-based global provider of radiation detection, measurement, and monitoring solutions serving the nuclear, medical, defense, and research end markets, saw its stock fall sharply on November 11, 2026. The shares declined roughly 8.15%, trading near $17.69, down from the prior session's closing price of $19.26. The move marked a notable reversal for a stock that had rallied strongly over the preceding month, and it unfolded as investors digested ongoing concerns about the company's margin trajectory following its late-October third-quarter report.
Profit-Taking After a Strong Run
A key driver of the pullback appears to be profit-taking following a powerful advance. MIR had climbed roughly 17% over the prior month, recovering from levels near $16 and pushing back toward recent multi-month highs. The stock's momentum was reinforced by an appearance at the Baird Global Industrial Conference, where management highlighted accelerating installed-base nuclear demand. After such a swift run, shares became vulnerable to a round of selling as traders locked in gains, a pattern common when a fast-moving rally pauses for air.
Margin Guidance and the Withdrawn 2028 Target
Beneath the surface, the selloff also reflects persistent unease about profitability. In its Q3 2026 results reported in late October, MIR delivered strong top-line and order momentum — organic orders rose 62% excluding acquisitions, driven by a 105% surge in nuclear-power-related orders — and it raised full-year revenue and free-cash-flow guidance. However, the company simultaneously lowered the high end of its adjusted EBITDA guidance to a range of $285 million to $292 million and, notably, withdrew its previously announced 2028 margin target.
Management attributed the reduced margin ambitions to front-loaded investments in artificial intelligence and cybersecurity, as well as slower organic growth in the Medical segment and tempered margin expectations for the Paragon acquisition. While framed as positioning for a "generational opportunity," the recalibration has left investors questioning near-term profitability, and that skepticism has continued to resurface in the shares.
Analyst Target Cuts and Cautious Ratings
The stock has also contended with a wave of more cautious analyst actions. Several firms trimmed their price targets following the earnings update, including reductions from B. Riley Securities, Robert W. Baird, J.P. Morgan, and Goldman Sachs. A sell-side downgrade to a Sell rating in some coverage added to the pressure. Although the broader consensus rating on MIR remains constructive, the direction of recent revisions — lower targets tied to margin concerns — has contributed to a more defensive tone among traders.
Market Context and Trading Activity
The decline came amid active trading, reflecting a rotation out of a momentum name rather than a broad-based collapse. The stock's retreat brought it back toward price levels seen earlier in the month, effectively erasing much of the gains built during the conference-driven pop. The shares remain well within their 52-week range of roughly $14.04 to $28.28, and the pullback did not breach the stock's longer-term lows. Sector-wise, nuclear and energy-related names have been supported by strong structural demand, but individual industrial names with margin-related overhangs have shown outsized intraday volatility.
What Comes Next for MIR
Looking ahead, investors will focus on the company's ability to convert its record backlog into revenue and demonstrate the promised margin expansion. Fourth-quarter results will be closely watched, given management's expectation for mid-to-high-teens organic revenue growth. The updated long-range guidance expected in early 2027, alongside any further detail on AI and cybersecurity spending, will be a key catalyst. Risks include slower-than-expected Medical-segment recovery, the pace of nuclear capital spending conversion, and the execution of Paragon integration. Order momentum remains a clear bright spot, but margin credibility will likely be the swing factor for sentiment in the near term.
Trending AI Robots
Tickeron offers hundreds of AI-powered trading bots covering thousands of tickers, but only the strongest performers under current market conditions are featured in its curated Trending AI Robots section. These bots vary by strategy, timeframe, performance metrics, and traded symbols, giving traders a range of automated approaches to consider. Explore the page to see which strategies are currently leading the market.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
MIR in upward trend: 10-day moving average moved above 50-day moving average on October 29, 2026
The 10-day moving average for MIR crossed bullishly above the 50-day moving average on October 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 20 of 22 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 28, 2026. You may want to consider a long position or call options on MIR as a result. In 70 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 74%.
The Moving Average Convergence Divergence (MACD) for MIR just turned positive on October 28, 2026. Looking at past instances where MIR's MACD turned positive, the stock continued to rise in 40 of 52 cases over the following month. The odds of a continued upward trend are 77%.
MIR moved above its 50-day moving average on October 28, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +13.72% 3-day Advance, the price is estimated to grow further. Considering data from situations where MIR advanced for three days, in 234 of 327 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.
The Aroon Indicator entered an Uptrend today. In 145 of 221 cases where MIR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 66%.
Bearish Trend Analysis
The 10-day RSI Indicator for MIR moved out of overbought territory on November 04, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In 18 of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at 60%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MIR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.
MIR broke above its upper Bollinger Band on October 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. MIR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 61 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock slightly better than average.
The Tickeron PE Growth Rating for this company is 71 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 89 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.394) is normal, around the industry mean (3.843). MIR has a moderately high P/E Ratio (199.667) as compared to the industry average of (36.971). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.879). Dividend Yield (0.000) settles around the average of (0.032) among similar stocks. P/S Ratio (4.281) is also within normal values, averaging (189.487).
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a blank check company, which engages in the merger capital stock exchange, asset acquisition, stock purchase, and reorganization.
Industry IndustrialMachinery
Advertisement